Fortress Biotech

company

Nasdaq SEC CIK 1429260 LEI 529900DZUWSYUURECK24
Follow Fortress Biotech Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $19.2M +8.7% vs same quarter last year
Net income −$5.8M −199.9% vs same quarter last year
EPS, diluted −$0.23 −309.1% vs same quarter last year
Operating cash flow −$6.2M −1.4% vs same quarter last year
Revenue by quarter
$15.1M
$13.1M
$16.4M
$17.6M
$16.1M
$16M
$18.7M
$19.2M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal years
  • Revenue
  • Net income
−$100M−$50M$0$50M$100MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$63.3M-
FY24$57.7M-
FY23$84.5M-
FY22$75.7M−$86.6M
FY21$68.8M−$64.7M
FY20$45.6M−$46.5M
FY19$36.6M−$40M
FY18$26.9M−$84.1M
FY17$17.2M−$66.9M
FY16$16.5M−$55.1M
FY15$863K−$48.4M
FY14$0−$20.4M
FY13$0−$37.2M
FY12-−$27.6M
FY11-−$36.4M
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−6000%−4000%−2000%0%2000%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2566.9%−111%-
FY2463.8%−191.4%-
FY2372.9%−168.4%-
FY2259.4%−268.8%−114.3%
FY2153.4%−274.1%−94.1%
FY2068%−206.7%−102%
FY1971.2%−302.5%−109.1%
FY1877.2%−446.4%−313%
FY1778.8%−520.7%−387.8%
FY1695.2%−398.7%−334.3%
FY15100%−5855.3%−5611.6%
FY14---
FY13---
FY12---
FY11---
Free cash flowOperating cash flow minus capital expenditure
−$200M−$150M−$100M−$50M$0FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25-
FY24−$80.2M
FY23−$128.3M
FY22−$182.1M
FY21−$121.1M
FY20−$85.6M
FY19−$97.3M
FY18−$105.9M
FY17−$82M
FY16−$52.2M
FY15−$20.7M
FY14−$16.3M
FY13−$29.7M
FY12−$23.2M
FY11−$11M
Returned to shareholdersDividends paid and shares bought back
  • Dividends
  • Buybacks
$0$200K$400K$600K$800KFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearDividendsBuybacks
FY25$664K-
FY24$694K-
FY23$736K-
FY22$749K-
FY21$749K-
FY20$237K$70K
FY19$0$0
FY18--
FY17--
FY16--
FY15--
FY14--
FY13--
FY12--
FY11--
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Fortress Biotech
  • Healthcare median
−6000%−4000%−2000%0%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFortress BiotechHealthcare median
FY25-−30.6%
FY24-−47%
FY23-−58%
FY22−114.3%−80.4%
FY21−94.1%−71.8%
FY20−102%−62.2%
FY19−109.1%−46.2%
FY18−313%−49.6%
FY17−387.8%−45.9%
FY16−334.3%−36%
FY15−5611.6%−37.8%
FY14-−35.5%
FY13-−37.1%
FY12-−29.1%
FY11-−27.9%